WO2025224598 - HER2 TARGETING CYCLIC PEPTIDES AND CONJUGATES THEREOF
National phase entry is expected:
Publication Number
WO/2025/224598
Publication Date
30.10.2025
International Application No.
PCT/IB2025/054153
International Filing Date
21.04.2025
Title **
[English]
HER2 TARGETING CYCLIC PEPTIDES AND CONJUGATES THEREOF
[French]
PEPTIDES CYCLIQUES CIBLANT HER2 ET CONJUGUÉS ASSOCIÉS
Applicants **
NOVARTIS AG
Inventors
CLEMENTE, Gonçalo dos Santos
EHARA, Takeru
FELBER, Richard
FISCHER, Matteo
GAUTER, Francois
KARPOV, Alexei
LACAUD-BAUMLIN, Marion
MALO, Rafael Bermeo
MARZINZIK, Andreas
MIZUKOSHI, Yoshihide
PARK, Danielle
RESCHKE, Markus Oliver
RIPOCHE, Sebastien
SCHAEFER, Michael
STACHYRA, Therese-Marie
UEDA, Kyosuke
ZUEGER, Patrik Peter
Priority Data
63/637,572
23.04.2024
US
63/760,270
19.02.2025
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 9773 | |
| EPO | Filing, Examination, Granting | 90873 | |
| Japan | Filing, Examination, Granting | 4473 | |
| South Korea | Filing, Examination, Granting | 6681 | |
| USA | Filing, Examination, Granting | 40740 |
Total:
152,540
Contact Us
Abstract[English]
Described herein are cyclic peptides targeting human epidermal growth factor receptor 2 (HER2), and their incorporation into compounds for radioligand imaging and therapies, as well as methods and/or uses of such compounds for the imaging, treatment and/or prevention of HER2-implicated diseases and disorders (e.g., cancer).[French]
L'invention concerne des peptides cycliques ciblant le récepteur 2 du facteur de croissance épidermique humain (HER2), et leur incorporation dans des composés pour l'imagerie et les thérapies par radioligands, ainsi que des méthodes et/ou des utilisations de tels composés pour l'imagerie, le traitement et/ou la prévention de maladies et de troubles impliquant HER2 (par exemple, le cancer).